The arrival of the Wegovy pill has opened the door for thousands of Britons to get their hands on the blockbuster medicine.
A once–daily tablet version of the Wegovy injection – which contains the same active ingredient, semaglutide – is the first GLP–1 weight–loss pill to be launched in the UK.
And demand has already surged, with pharmacies reporting tens of thousands of orders after the tablets were officially rolled out across Britain on Monday.
The ‘unprecedented’ interest reflects the public intrigue around the pill, which can help patients shed around 17 per cent of their body weight in 64 weeks.
It is expected to appeal
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
